The STEP-HFpEF trial randomised 529 patients with obesity (BMI 30 kg/m 2 ), HFpEF (left ventricular ejection fraction [LVEF] 45%) and New York Heart Association (NYHA) Class II symptoms to once-weekly subcutaneous semaglutide 2.4 mg or placebo
The functional medicine approach how to pair GLP-1 therapy with tailored nutrition, movement, and stress management plans
Available from: Arons A, Bolbocean C, Bush NR, Tylavsky FA, LeWinn KZ
Allergic reactions (hives, wheezing, difficulty breathing)
The combination of analytical transparency and consistent fulfillment makes Iron Labs a trusted source for premium research materials supplied to academic, contract, and independent laboratory environments
The ingredients in MICC injections help the body break down fats and carbohydrates, which can aid in weight loss